Short-Term Efficacy of Eculizumab Therapy in Atypical Hemolytic Uremic Syndrome
Tanvi Bindal(All India Institute of Medical Sciences), Arvind Bagga(All India Institute of Medical Sciences), Anand Narain Tiwari(All India Institute of Medical Sciences), Pankaj Hari(Indian Council of Medical Research), Aditi Sinha
Cited by 0
Related Papers
Clinical Features of Anti-Factor H Autoantibody–Associated Hemolytic Uremic Syndrome
|Journal of the American Society of Nephrology|2010|296
Prompt plasma exchanges and immunosuppressive treatment improves the outcomes of anti-factor H autoantibody-associated hemolytic uremic syndrome in children
|Kidney International|2013|216
Efficacy and Safety of Treatment with Rituximab for Difficult Steroid-Resistant and -Dependent Nephrotic Syndrome
|Clinical Journal of the American Society of Nephrology|2010|203
Efficacy and Safety of Tacrolimus Versus Cyclosporine in Children With Steroid-Resistant Nephrotic Syndrome: A Randomized Controlled Trial
|American Journal of Kidney Diseases|2009|176
Mycophenolate mofetil and prednisolone therapy in children with steroid-dependent nephrotic syndrome
|American Journal of Kidney Diseases|2003|140